{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T16:05:28Z","timestamp":1761581128056},"reference-count":34,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2013,10,5]],"date-time":"2013-10-05T00:00:00Z","timestamp":1380931200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Eur Radiol"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1007\/s00330-013-3020-x","type":"journal-article","created":{"date-parts":[[2013,10,4]],"date-time":"2013-10-04T05:08:02Z","timestamp":1380863282000},"page":"405-412","source":"Crossref","is-referenced-by-count":51,"title":["18F-FDG PET\/CT for detection of malignant peripheral nerve sheath tumours in neurofibromatosis type 1: tumour-to-liver ratio is superior to an SUVmax cut-off"],"prefix":"10.1007","volume":"24","author":[{"given":"Johannes","family":"Salamon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Veldhoen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ivayla","family":"Apostolova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Bannas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yamamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jochen","family":"Herrmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard E.","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerhard","family":"Adam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor F.","family":"Mautner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thorsten","family":"Derlin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2013,10,5]]},"reference":[{"key":"3020_CR1","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S0022-3476(05)80639-0","volume":"116","author":"R Listernick","year":"1990","unstructured":"Listernick R, Charrow J (1990) Neurofibromatosis type 1 in childhood. J Pediatr 116:845\u2013853","journal-title":"J Pediatr"},{"key":"3020_CR2","unstructured":"Conference Statement (1988) Neurofibromatosis. Conference statement. National Institutes of Health Consensus Development Conference. Arch Neurol 45:575\u2013578"},{"key":"3020_CR3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1053\/ejso.1998.0625","volume":"25","author":"RC Ramanathan","year":"1999","unstructured":"Ramanathan RC, Thomas JM (1999) Malignant peripheral nerve sheath tumours associated with von Recklinghausen\u2019s neurofibromatosis. Eur J Surg Oncol 25:190\u2013193","journal-title":"Eur J Surg Oncol"},{"key":"3020_CR4","first-page":"197","volume":"36","author":"JM McGaughran","year":"1999","unstructured":"McGaughran JM, Harris DI, Donnai D et al (1999) A clinical study of type 1 neurofibromatosis in north west England. J Med Genet 36:197\u2013203","journal-title":"J Med Genet"},{"key":"3020_CR5","first-page":"1573","volume":"62","author":"RE Ferner","year":"2002","unstructured":"Ferner RE, Gutmann DH (2002) International consensus statement on malignant peripheral nerve sheath tumors in neurofibromatosis. Cancer Res 62:1573\u20131577","journal-title":"Cancer Res"},{"key":"3020_CR6","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1002\/1097-0142(19860515)57:10<2006::AID-CNCR2820571022>3.0.CO;2-6","volume":"57","author":"BS Ducatman","year":"1986","unstructured":"Ducatman BS, Scheithauer BW, Piepgras DG et al (1986) Malignant peripheral nerve sheath tumors. A clinicopathologic study of 120 cases. Cancer 57:2006\u20132021","journal-title":"Cancer"},{"key":"3020_CR7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1136\/jmg.39.5.311","volume":"39","author":"DGR Evans","year":"2002","unstructured":"Evans DGR, Baser ME, McGaughran J et al (2002) Malignant peripheral nerve sheath tumours in neurofibromatosis 1. J Med Genet 39:311\u2013314","journal-title":"J Med Genet"},{"key":"3020_CR8","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1097\/00000658-198704000-00003","volume":"205","author":"W Lawrence","year":"1987","unstructured":"Lawrence W, Donegan WL, Natarajan N et al (1987) Adult soft tissue sarcomas. A pattern of care survey of the American College of Surgeons. Ann Surg 205:349\u2013359","journal-title":"Ann Surg"},{"key":"3020_CR9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/(SICI)1096-8628(19990326)89:1<31::AID-AJMG7>3.0.CO;2-W","volume":"89","author":"BR Korf","year":"1999","unstructured":"Korf BR (1999) Plexiform neurofibromas. Am J Med Genet 89:31\u201337","journal-title":"Am J Med Genet"},{"key":"3020_CR10","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00234-005-0033-4","volume":"48","author":"VF Mautner","year":"2006","unstructured":"Mautner VF, Hartmann M, Kluwe L et al (2006) MRI growth patterns of plexiform neurofibromas in patients with neurofibromatosis type 1. Neuroradiology 48:160\u2013165","journal-title":"Neuroradiology"},{"key":"3020_CR11","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1212\/01.wnl.0000168830.79997.13","volume":"65","author":"T Tucker","year":"2005","unstructured":"Tucker T, Wolkenstein P, Revuz J et al (2005) Association between benign and malignant peripheral nerve sheath tumors in NF1. Neurology 65:205\u2013211","journal-title":"Neurology"},{"key":"3020_CR12","doi-asserted-by":"crossref","first-page":"11S","DOI":"10.2967\/jnumed.108.057182","volume":"50","author":"R Boellaard","year":"2009","unstructured":"Boellaard R (2009) Standards for PET image acquisition and quantitative data analysis. J Nucl Med 50:11S\u201320S","journal-title":"J Nucl Med"},{"key":"3020_CR13","first-page":"424","volume":"46","author":"CJ Jaskowiak","year":"2005","unstructured":"Jaskowiak CJ, Bianco JA, Perlman SB, Fine JP (2005) Influence of reconstruction iterations on 18F-FDG PET\/CT standardized uptake values. J Nucl Med 46:424\u2013428","journal-title":"J Nucl Med"},{"key":"3020_CR14","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1007\/s00259-008-1038-0","volume":"36","author":"VS Warbey","year":"2009","unstructured":"Warbey VS, Ferner RE, Dunn JT et al (2009) [18F]FDG PET\/CT in the diagnosis of malignant peripheral nerve sheath tumours in neurofibromatosis type-1. Eur J Nucl Med Mol Imaging 36:751\u2013757","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3020_CR15","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1093\/annonc\/mdm450","volume":"19","author":"RE Ferner","year":"2008","unstructured":"Ferner RE, Golding JF, Smith M et al (2008) [18F]2-fluoro-2-deoxy-D-glucose positron emission tomography (FDG PET) as a diagnostic tool for neurofibromatosis 1 (NF1) associated malignant peripheral nerve sheath tumours (MPNSTs): a long-term clinical study. Ann Oncol 19:390\u2013394","journal-title":"Ann Oncol"},{"key":"3020_CR16","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00259-005-0030-1","volume":"33","author":"W Brenner","year":"2006","unstructured":"Brenner W, Friedrich RE, Gawad KA et al (2006) Prognostic relevance of FDG PET in patients with neurofibromatosis type-1 and malignant peripheral nerve sheath tumours. Eur J Nucl Med Mol Imaging 33:428\u2013432","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3020_CR17","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1002\/cncr.24755","volume":"116","author":"MR Benz","year":"2010","unstructured":"Benz MR, Czernin J, Dry SM et al (2010) Quantitative F18-fluorodeoxyglucose positron emission tomography accurately characterizes peripheral nerve sheath tumors as malignant or benign. Cancer 116:451\u2013458","journal-title":"Cancer"},{"key":"3020_CR18","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1007\/s00259-012-2314-6","volume":"40","author":"J Salamon","year":"2012","unstructured":"Salamon J, Derlin T, Bannas P et al (2012) Evaluation of intratumoural heterogeneity on (18)F-FDG PET\/CT for characterization of peripheral nerve sheath tumours in neurofibromatosis type 1. Eur J Nucl Med Mol Imaging 40:685\u2013692","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3020_CR19","first-page":"1","volume":"34","author":"P Lindholm","year":"1993","unstructured":"Lindholm P, Minn H, Leskinen-Kallio S et al (1993) Influence of the blood glucose concentration on FDG uptake in cancer\u2014a PET study. J Nucl Med 34:1\u20136","journal-title":"J Nucl Med"},{"key":"3020_CR20","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1007\/s002590100566","volume":"28","author":"D Visvikis","year":"2001","unstructured":"Visvikis D, Cheze-LeRest C, Costa DC et al (2001) Influence of OSEM and segmented attenuation correction in the calculation of standardised uptake values for [18F]FDG PET. Eur J Nucl Med 28:1326\u20131335","journal-title":"Eur J Nucl Med"},{"key":"3020_CR21","first-page":"1431","volume":"45","author":"JA Thie","year":"2004","unstructured":"Thie JA (2004) Understanding the standardized uptake value, its methods, and implications for usage. J Nucl Med 45:1431\u20131434","journal-title":"J Nucl Med"},{"key":"3020_CR22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1080\/10428190903040048","volume":"50","author":"M Meignan","year":"2009","unstructured":"Meignan M, Gallamini A, Haioun C (2009) Report on the first international workshop on interim-PET-scan in lymphoma. Leuk Lymphoma 50:1257\u20131260","journal-title":"Leuk Lymphoma"},{"key":"3020_CR23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1007\/s00259-010-1490-5","volume":"37","author":"SF Barrington","year":"2010","unstructured":"Barrington SF, Qian W, Somer EJ et al (2010) Concordance between four European centres of PET reporting criteria designed for use in multicentre trials in Hodgkin lymphoma. Eur J Nucl Med Mol Imaging 37:1824\u20131833","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"3020_CR24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.2967\/jnumed.108.060574","volume":"50","author":"JW Lee","year":"2009","unstructured":"Lee JW, Paeng JC, Kang KW et al (2009) Prediction of tumor recurrence by 18F-FDG PET in liver transplantation for hepatocellular carcinoma. J Nucl Med 50:682\u2013687","journal-title":"J Nucl Med"},{"key":"3020_CR25","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1002\/ijc.2910330108","volume":"33","author":"M Trojani","year":"1984","unstructured":"Trojani M, Contesso G, Coindre JM et al (1984) Soft-tissue sarcomas of adults; study of pathological prognostic variables and definition of a histopathological grading system. Int J Cancer 33:37\u201342","journal-title":"Int J Cancer"},{"key":"3020_CR26","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/00000478-199712000-00006","volume":"21","author":"BT Lin","year":"1997","unstructured":"Lin BT, Weiss LM, Medeiros LJ (1997) Neurofibroma and cellular neurofibroma with atypia: a report of 14 tumors. Am J Surg Pathol 21:1443\u20131449","journal-title":"Am J Surg Pathol"},{"key":"3020_CR27","doi-asserted-by":"crossref","unstructured":"Treglia G, Taralli S, Bertagna F et al (2012) Usefulness of whole-body fluorine-18-fluorodeoxyglucose positron emission tomography in patients with neurofibromatosis type 1: a systematic review. Radiol Res Pract 2012:431029","DOI":"10.1155\/2012\/431029"},{"key":"3020_CR28","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1016\/S0168-8278(00)80248-2","volume":"32","author":"MA Khan","year":"2000","unstructured":"Khan MA, Combs CS, Brunt EM et al (2000) Positron emission tomography scanning in the evaluation of hepatocellular carcinoma. J Hepatol 32:792\u2013797","journal-title":"J Hepatol"},{"key":"3020_CR29","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1093\/annonc\/mdq557","volume":"22","author":"C Furth","year":"2011","unstructured":"Furth C, Amthauer H, Hautzel H et al (2011) Evaluation of interim PET response criteria in paediatric Hodgkin\u2019s lymphoma\u2014results for dedicated assessment criteria in a blinded dual-centre read. Ann Oncol 22:1198\u20131203","journal-title":"Ann Oncol"},{"key":"3020_CR30","doi-asserted-by":"crossref","first-page":"541","DOI":"10.2967\/jnumed.110.083717","volume":"52","author":"JF Eary","year":"2011","unstructured":"Eary JF, Link JM, Muzi M et al (2011) Multiagent PET for risk characterization in sarcoma. J Nucl Med 52:541\u2013546","journal-title":"J Nucl Med"},{"key":"3020_CR31","doi-asserted-by":"crossref","unstructured":"Buck AK, Herrmann K, B\u00fcschenfelde CM zum et al (2008) Imaging bone and soft tissue tumors with the proliferation marker [18F]fluorodeoxythymidine. Clin Cancer Res 14:2970\u20132977","DOI":"10.1158\/1078-0432.CCR-07-4294"},{"key":"3020_CR32","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2214\/AJR.09.2724","volume":"194","author":"J Wasa","year":"2010","unstructured":"Wasa J, Nishida Y, Tsukushi S et al (2010) MRI features in the differentiation of malignant peripheral nerve sheath tumors and neurofibromas. AJR Am J Roentgenol 194:1568\u20131574","journal-title":"AJR Am J Roentgenol"},{"key":"3020_CR33","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00432-008-0523-y","volume":"135","author":"A Matsumine","year":"2009","unstructured":"Matsumine A, Kusuzaki K, Nakamura T et al (2009) Differentiation between neurofibromas and malignant peripheral nerve sheath tumors in neurofibromatosis 1 evaluated by MRI. J Cancer Res Clin Oncol 135:891\u2013900","journal-title":"J Cancer Res Clin Oncol"},{"key":"3020_CR34","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1097\/RLU.0b013e318266ce84","volume":"38","author":"T Derlin","year":"2013","unstructured":"Derlin T, Tornquist K, M\u00fcnster S et al (2013) Comparative effectiveness of 18F-FDG PET\/CT versus whole-body MRI for detection of malignant peripheral nerve sheath tumors in neurofibromatosis type 1. Clin Nucl Med 38:e19\u2013e25","journal-title":"Clin Nucl Med"}],"container-title":["European Radiology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-013-3020-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00330-013-3020-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00330-013-3020-x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,7,28]],"date-time":"2019-07-28T21:26:28Z","timestamp":1564349188000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00330-013-3020-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,10,5]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["3020"],"URL":"https:\/\/doi.org\/10.1007\/s00330-013-3020-x","relation":{},"ISSN":["0938-7994","1432-1084"],"issn-type":[{"value":"0938-7994","type":"print"},{"value":"1432-1084","type":"electronic"}],"subject":[],"published":{"date-parts":[[2013,10,5]]}}}